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ABSTRAK
Kajian genetik terdahulu menunjukkan bahawa kelangsungan hidup dan proliferasi 
parasit Plasmodium falciparum bergantung kepada penggunaan purin utama 
dalam hos. Plasmodium falciparum, agen penyebab kepada jenis malaria paling 
merbahaya pada manusia, tidak mempunyai enzim yang diperlukan untuk sintesis 
purin  secara de novo. Berdasarkan kepada sasaran kemoterapeutik yang novel, 
analisa hipotetikal protein pengangkut nukleosida/nukleobas, hasil dari gen PfNT3 
(PF14_0662) dalam parasit P. falciparum, dilakukan secara lokalisasi. Melalui 
immunobloting, immunoflorescen dan lokalisasi mikroskopik immunoelektron, 
lokasi PfNT3 didemonstrasi dengan menggunakan anti-serum poliklonal pada 
kultur in-vitro parasit  P. falciparum  yang dibiakkan dalam sel darah merah manusia. 
Protin PfNT3, hasil translasi gen PfNT3, dikesan pada peringkat cincin intraeritrosit, 
tropozit dan skizon. Tumpuan utama PfNT3 adalah pada membran plasma parasit 
(MPP). Pengangkut putatif nukleosid endogenous PfNT3 dengan lokasi utama di 
MPP boleh bertindak bukan sahaja sebagai tapak jalan untuk sasaran analog purin/ 
agen sitotoksik bagi intraselular parasit , tetapi juga bertindak sebagai sasaran dadah. 
Sebagai genom terkod, protin pengangkut vital boleh dihalang daripada diekspresi 
melalui gen ‘silencing’ dan ini mengesahkanya sebagai sasaran dadah yang novel.
Kata kunci: Pengangkut nukleosida equilibratif, malaria, gen PfNT3, Plasmodium 
falciparum, purin.  
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ABSTRACT 
Previous genetic studies demonstrated that survival and proliferation of Plasmodium 
falciparum parasites is dependent on salvage of essential purines from the host. 
Plasmodium falciparum, the causative agent of the most lethal form of human 
malaria lacks the enzymes required for de novo synthesis of purines. Analysis of 
the hypothetical nucleoside/nucleobase transporter protein, the gene product of 
PfNT3 (PF14_0662) gene in P. falciparum parasites was carried out by localisation, 
in view of a novel chemotherapeutic target.  Immunoblotting, immunofluorescent 
and immunoelectron microscopic localization of PfNT3 was demonstrated 
using polyclonal antiserum in in vitro cultured Plasmodium falciparum parasites, 
propagated in human red blood cells.  PfNT3 protein, the translated product of 
PfNT3 gene was detected in intraerythrocytic ring, trophozoite, and schizont 
stages. PfNT3 was localized primarily to the PPM (Parasite Plasma Membrane). The 
endogenous PfNT3 putative nucleoside transporter with the predominant location 
to the parasite plasma membrane may serve not only as routes for targeting of 
purine analogs/cytotoxic agents into the intracellular parasite but may also serve as 
drug targets. Being genome encoded the vital transporter protein can be prevented 
from expression by silencing of the gene, validating it to be a novel drug target. 
Keywords: equilibrative nucleoside transporter, malaria, PfNT3 gene, Plasmodium 
falciparum, purines.  
INTRODUCTION 
Malaria can be considered as one of 
the oldest and deadliest infectious 
diseases around the world. It continues 
to be one of the major public health 
problems in the world especially 
in African and South-East Asian 
countries (Kondrachine et al. 1997). 
As per the World Malaria Report, 
2008, in terms of malaria incidence, 
India ranks 15th among 109 countries 
and contributed approximately 2% of 
global cases in 2006. India accounted 
for approximately two thirds of the 
confirmed cases reported in the South-
East Asia region. Five states accounted 
for 60% of cases i.e. Orissa, Chhattisgarh, 
Madhya Pradesh, Jharkhand and West 
Bengal (Global Reports: World Health 
Organisation 2011). The state of Odisha, 
part of peninsular India is situated along 
the east coast extending from 170 49’ to 
220 34’ N and 810 28’ to 870 29’ E. It is 
hyper-endemic for malaria. With 4% of 
India’s population, the state contributed 
28.6% of total malaria cases, 35% of 
P. falciparum cases and 50% of total 
malaria deaths in the country (Ranjit et 
al. 2005). 
 Plasmodium falciparum causes one 
of the most life-threatening infections in 
humans. Despite all control measures, 
malaria still remains uncontrolled. 
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Chemotherapy for malaria is the 
dominant mode of intervention since 
a vaccine for the disease is still not a 
reality. The most important factor is 
the development of resistance by P. 
falciparum to conventional and effective 
drugs like chloroquine, mefloquine, 
naturally occurring quinine and 
sulfadoxine/ pyrimethamine (Biot et al. 
2006). Antimalarial drug development 
can follow several strategies, ranging 
from modifications of existing agents 
to design of novel agents that act 
against new targets. The rapid growth 
and multiplication rate of the malaria 
parasite during the intra erythrocytic life 
cycle with its metabolism intertwined 
with that of the host necessitates the 
parasite to acquire nutrients from 
the host cell. Purines enter the host 
erythrocyte  via a combination of 
endogenous transporters and “new 
permeation pathways” induced in the 
erythrocyte membrane as the parasite 
matures (Gero et al. 1988; Gati et al. 
1990; Upston et al. 1995; Quashie et 
al. 2010). The enclosure of Plasmodium 
falciparum in a parasitophorous vacuole 
inside the erythrocytes necessitates the 
uptake of nutrients or purines from host 
erythrocyte  into P. falciparum across 
a multiplicity of membranes: the Red 
Blood Cell membrane (RBCM), the 
Parasitophorous Vacuolar Membrane 
(PVM) and the Parasite Plasma 
Membrane (PPM). A variety of complex 
and novel components may also 
be involved, including transporters, 
channels, ducts and tubulo vesicular 
membranes (TVM). 
 One striking metabolic difference 
between all parasites and their 
mammalian hosts is the purine 
synthetic pathway. The mammalian 
cells are capable of synthesizing 
purine nucleotides de novo while the 
protozoan parasites studied to date 
including P. falciparum is incapable of 
making a purine ring (Shermann et al. 
1979; Gero et al. 1990; World Health 
Organization 1997; World Health 
Organization Expert Committee on 
Malaria 2000). The enzymes of the 
salvage pathway for purine nucleotides 
have all been demonstrated in the 
infected erythrocyte. This purine 
salvage process is initiated by the 
translocation of purines across the 
parasite membranes. Thus, the 
transport characteristics of purine base 
and nucleoside transporters serve an 
indispensable nutritional function for 
the parasite, which may be a novel 
drug target (Carter et al. 2000).
 A P. falciparum encoded 
Equilibrative Nucleoside Transporter 
(ENT), the PF13_0252 (PfENT1) protein 
has been characterized in Xenopus 
oocytes and observed to transport 
purine and pyrimidine nucleosides and 
nucleobases (Carter et al. 2000; Martin et 
al. 2005). Functional analysis by genetic 
disruption in Plasmodium falciparum 
indicated that PfNT1 is essential for 
parasite survival under physiologic 
purine concentrations (El Bissati et al. 
2008). It was also reported that PfNT1 
knock-out parasites were unable to 
transport most physiologically relevant 
purine nucleosides/ nucleobases, 
although residual adenine transport 
was observed (El Bissati et al. 2008; El 
Bissati et al. 2006). 
 The completion of the Plasmodium 
genome sequencing project (Gardner 
et al. 2002) also revealed three 
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further ENT family members, PfNT2 
(MAL8P1.32), PfNT3 (PF14_0662), 
and PfNT4 (PFA0160c). Like PfNT1, 
PfNT2, an intracellular permease is a 
member of the equilibrative nucleoside 
transporter family. Confocal and 
immunoelectron microscopic analyses 
of transgenic parasites harbouring green 
fluorescent protein- or haemagglutinin-
tagged PfNT2 demonstrated 
endoplasmic reticulum localization. 
This study provided the first evidence 
of an intracellular purine permease in 
apicomplexan parasites and suggests 
a novel biological function for the 
parasite endoplasmic reticulum during 
malaria infection (Downie et al. 2010).
 The complexity of the intra 
erythrocytic environment where the 
parasite resides reveals that the location 
of PfNT3 and other putative members of 
P. falciparum ENT family are important 
because a restricted milieu can be a 
determinant of specialized functions 
and their potential as therapeutic 
targets. These may be novel sites of 
therapeutic targets. These predictions 
led to the importance of the study 
of putative nucleoside/nucleobase 
transporter, PfNT3 in in vitro cultured 
Plasmodium falciparum parasites 
propagated in human red blood cells. 
Such studies on PfNT3 are not yet 
reported in literature. 
 MATERIALS & METHODS 
STUDY DESIGN
Study of PfNT3 gene product by 
immunoblotting, immunofluorescence 
and immunoelectron microscopic 
localization was demonstrated in this 
work. This was based on in vitro culture 
of Plasmodium falciparum parasites, 
cloning, expression of the gene and 
polyclonal antibody development 
against the putative nucleoside/
nucleobase transporter after approval 
of the Institutional Ethics Committee.
PARASITE CULTURE AND 
ANALYSIS OF PFNT3
RKL9 Clone of P. falciparum parasites 
(a strain of P. falciparum parasite in 
Rourkela, an endemic zone of malaria 
in the state of Odisha, India) obtained 
from National Institute of Malaria 
Research (NIMR), Delhi, India were 
propagated in human RBCs at 2% 
haematocrit and 1-10% parasitemia 
in RPMI-1640 medium (Himedia, 
India) supplemented with 10% heat 
inactivated human serum (O+ or AB+) 
(Trager et al. 1976). 
 PfNT3 sequence was amplified by 
polymerase chain reaction with genomic 
DNA from the in vitro cultured P. 
falciparum parasites using a sense primer 
- 5’- GCGTCATGAGTGACAGTCAGAG 
- 3’ (22 mer) and anti-sense primer - 5’- 
GCTCGAGTTTTAAAATAACTGC - 3’ 
(24 mer), respectively. Optimized PCR 
conditions were initial denaturation 
at 980C for 2 mins., 30 cycles of 
denaturation at 980C for 30 secs., 
annealing at 45.70C for 30 secs., 
extension at 720C for 45 secs. and final 
extension at 720C for 10 mins. PCR 
product was identified by 1% agarose gel 
electrophoresis and sequencing. All the 
sequencing reactions were carried out 
with routine procedure of sequencing 
(commercially in an ABI 3130 genetic 
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and   anti-sense primer - 5’ - CAAAAGT 
ATCCTCGAGTTCAATATCACAAGG 
-3’ (Bangalore Genei, India) with 
engineered BamHI and XhoI restriction 
sites (strike through), respectively. The 
optimized PCR conditions were initial 
denaturation at 980C for 10 secs, 
annealing at 550C for 10 secs, extension 
at 720C for 10 secs and a final extension 
at 720C for 5 mins. The PCR product 
was identified by 1.5% agarose gel 
electrophoresis and sequencing.
 To generate an antigen for screening 
and purifying PfNT3-specific 
antibodies, the purified PCR product 
of PfNT3-1-108 sequence was cloned 
to pGEMT cloning vector, sub cloned 
into BamH1, Xho1 sites of pGEX-4T-1 
(Amersham, USA) expression plasmid 
vector to create pGEX-4T-1-PfNT3-1-108 
recombinant construct. Sequencing of 
cloned recombinant product was done 
to confirm proper ligation and reading 
frame. The recombinant construct was 
transformed into E. coli BL21 (DE 3) 
expression host for expression of the 
GST tagged fusion protein as described 
(Rabhi-Essafi et al. 2007). Expression 
was induced with 0.1 mM Isopropyl 
ß-D-thiogalactoside. The expressed 
soluble recombinant fusion protein was 
analysed by SDS-PAGE and purified as 
per the New England Bio labs brochure. 
The NH2 terminal polypeptide of 36 
amino acids was separated from the 
GST tagged recombinant protein by 
thrombin enzyme digestion and passage 
through the GST affinity column. The 
purified fusion protein was sent to 
Bangalore Genei, India for polyclonal 
antisera production. The antibodies 
were screened initially against the 
pre-immune serum and pGEX-4T-1- 
analyzer, USA at Manipal Life Sciences 
Centre, Manipal University, Karnataka, 
India). The PfNT3 PCR product in the 
excised gel was processed by QIAquick 
Gel Extraction Kit (Qiagen, Germany).
Sequencing of the purified DNA was 
done in both directions. At least three 
independent clones were sequenced 
and each nucleotide was confirmed 
with an average of five times. Analysis 
of the sequenced PCR product and the 
deduced amino acid sequence was 
done by BLAST with the 3D7 strain 
(Plasmo DB database). The antigenicity 
and the hydophilicity property of the 
deduced amino acid sequence were 
found out (Hopp et al. 1981; Kyte et al. 
1982).
 For study of identities, similarities 
and conserved regions of PfNT3, 
homology of the deduced PfNT3 
amino acid sequence was searched by 
multiple sequence alignment (Clustal 
W2.0 program) after downloading 
different nucleoside transporter 
homologues from NCBI. The 
phylogenetic relationship was observed 
with PhyloDraw ver. 0.8. Topology 
was studied to predict the number of 
transmembane helices, positions of 
the N-terminal, the C-terminal and 
distribution of amino acids in different 
regions of the translated product 
(TMHMM software). 
PFNT3 ANTIBODIES
 A 108 bp fragment of the  PfNT3 open 
reading frame encoding the 36 NH2-
terminal amino acids of PfNT3 was 
amplified  by polymerase chain reaction 
using a sense primer - 5’ - CGGGA 
TGGATCCATGAGTGACAGTCAG - 3’, 
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PfNT3-1-108 proteins by direct ELISA 
and Western blotting. Antibodies were 
purified using antigen immobilized 
agarose by Cyanogen Bromide method 
following manufacturer’s protocol. 
Sensitivity and specificity of antibodies 
in the polyclonal sera was detected 
by ELISA and Western blotting. The 
pelleted parasites were lysed with Triton 
X-100 and sonicated gently for isolation 
of the parasite membrane fraction. 
Proteins were fractionated by 10% SDS 
PAGE.
LOCALIZATION
IMMUNOBLOTTING
SDS PAGE fractionated membrane 
pellete, GST tag removed expressed 
protein, GST and preimmune serum 
were transferred to a polyvinylidene 
fluoride membrane (Millipore) by 
semidry blot method. The membrane 
was blocked with 5% milk powder 
(Millipore) in 1x TBS. Probing was 
done with purified developed primary 
antibody  (dilution,1:1,000) and 
horseradish peroxidase conjugated 
Goat anti-rabbit IgG secondary 
antibody (dilution,1:20,000). A super 
signal west Pico Chemiluminescence kit 
(Thermo Scientific) was used to detect 
the proteins following manufacturer’s 
protocol.
IMMUNOFLUORESCENCE 
MICROSCOPY 
Slides for IFA were prepared as per 
standard procedure of slide preparation 
(Nicolle et al. 2001). In brief, RBCs 
harbouring an asynchronous culture 
of P. falciparum were washed twice in 
PBS, placed onto coverslips and dried at 
room temperature. Smears were fixed 
in ice cold acetone/methanol (70:30) at 
-200C for 5 mins, followed by rinsing 3 
times in PBS and blocking in 2% (w/v) 
BSA. A PBS wash buffer containing 
0.2% BSA, 2% goat serum was used for 
subsequent washes and incubations. 
Coverslips were incubated with purified 
PfNT3 antibodies (dilution: 1:50) for 4 h 
at room temperature. Controls included 
fixed parasites incubated with pre-
immune antiserum. Smears were further 
treated with fluorescein isothiocyanate 
(FITC) conjugated secondary goat anti-
primary antibody at 1: 300 dilutions 
for 1hr following the washing step. The 
cover slips were rinsed again with PBS 
washing buffer followed by incubation 
in 10 uM final concentration of Hoechst 
stain (Sigma) for 5 min. Mounting of 
cover slips on slides was done using 
vectashield mounting media (Vector 
Laboratories). Images were captured 
at intervals of 0.3µuM along the Z axis 
using a Leica TCS SP5 AoBS Confocal 
microscope. Analysis of images was 
done by the LAS AF software version 
2.0 at Centre for Cellular and Molecular 
Biology, Hyderabad, India.
  
IMMUNOELECTRON 
MICROSCOPY
Pelleted parasitized RBCs in a solution 
of 4% paraformaldehyde, 200 mM 
PIPES and 0.5 mM MgCl2, pH 7.0 
were fixed on ice for one hour. The 
cell pellete was fixed for 30 minutes at 
room temperature in 10% gelatin after 
rinsing in PIPES buffer. Fixed samples 
were incubated overnight at 40C in 20% 
polyvinylpyrrolidone and 2.3 M sucrose 
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in PIPES buffer. Samples were rapidly 
frozen in liquid ethane, cryosectioned 
and collected on carbon-Formvar-
coated grids at Centre for Cellular 
and Molecular Biology, Hyderabad, 
India. Blocking was done with 5% 
foetal bovine serum, 5% goat serum in 
PIPES buffer followed by incubation in 
purified primary antibody (1:50 dilution) 
for 1hr at room temperature. Grids 
were rinsed, incubated with anti-rabbit 
secondary antibodies conjugated to 10 
nm gold particles. Counterstaining was 
done with 0.3% uranyl acetate and 2% 
polyvinyl alcohol. Images were viewed 
on a 200 KV transmission electron 
microscope. 
RESULTS 
ANALYSIS OF PfNT3 AND THE 
TRANSLATIONAL PRODUCT
The P. falciparum PfNT3 protein is 
a polypeptide of 437 amino acids 
encoded by a 1314 bp segment of 
DNA. Agarose gel eletrophoresis of 
amplified PCR product detected a 1.3 
kb DNA (Figure 1) and approximately 
a 0.1kb band (Figure 2). The whole 
sequence analysed was significantly 
matching with the sequence of PfNT3 
in PlasmoDB data base. 
CHARACTERIZATION OF 
ANTIGEN
Hydrophobicity profile of the deduced 
amino acid sequence by Kyte and 
Doolittle hydropathy plot (data not 
shown) indicated PfNT3 to be a 
highly hydrophobic protein with 11 
trans membrane helices. Predicted 
by homology study (Clustal W2.0 
program, Figure 3), the deduced amino 
acid sequence was homologous to 
a number of ENTs, such as hENT1, 
hENT2, TbNT2, LdNT1.1, TgAT, PfENT1 
and Fun26. T, D, P, R & G amino acid 
residues were identical in particular 
regions of sequences but frequency of 
G was more. L, N, E, F, R & S amino 
acids were observed as conserved 
substitutions with more frequency off. 
Semi conserved substitutions were also 
observed. More homology was found 
Figure 1: Analysis of PfNT3 PCR products 
on 0.8% agarose gel electrophoresis. Lane 
1-Molecular marker lane; Lane 2 & 3-1.3Kb 
PCR product; Lane 4-negative control
 Figure 2: Analysis of PfNT3-1-108 
sequence PCR products on 1.5% agarose gel 
electrophoresis. Lane 1-Molecular marker lane; 
Lane 2 - 5-PCR product of N-terminal; Lane 
6-negative control
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with nucleoside transporter homologues 
of PfENT1 and Fun26 (Figure 3). 
Obtained PfNT3 sequencewas more 
related to Yeast nucleoside transporter 
FUN26 and PfENT1 (Figure 4). Predicted 
topology analysis (TMHMM software) 
of the deduced amino acid sequence of 
PfNT3 presented an integral membrane 
protein with eleven trans membrane 
helices and an intracellular hydrophilic 
region between helices 6 and 7. It also 
revealed a cytoplasmic NH2 terminal 
of 49 amino acids and a short carboxyl 
terminal of 8 amino acids lying outside 
the membrane (Figure 5).
CHARACTERIZATION OF 
ANTIGEN AND ANTIBODY 
SPECIFICTY
The expressed GST tagged PfNT3-
1-108 protein was of approximately 
31.6 kDa as estimated from SDS-PAGE 
analysis (Figure 6). Purified polyclonal 
antibodies recognized a polypeptide 
Figure 3: Homology study by alignment of PF14_0662 amino acid sequence with other 
nucleoside transporter homologues (By ClustalW2.0) 
Figure 4: Phylogenetic tree showing 
relationship between PF14_0662 with other 
nucleoside transporter proteins by Phylodraw 
ver. 0.8. PF14_0662-P. falciparum nucleoside 
transporter; Fun26-nucleoside transporter 
from Saccharomyces cerevisiae; PfENT1-the 
first nucleoside transporter from P. falciparum; 
TgAT-nucleoside transporter from Toxoplasma 
gondii; TbNT2-the P1 type transporter from 
T. brucei; LdNT1.1-Leishmania donovani 
transporter-1; ZK809.4, K02E11.1, F16H11.3, 
C47A4.2-nucleoside transporter from C. 
elegans; F1701.13-a nucleoside transporter 
from Arabidopsis thaliana
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with a molecular mass of 31.6 kDa 
(Figure 7-A). The single polypeptide 
in immunoblotting with thrombin 
digested GST tag removed expressed 
protein was recognized as a band of 
size 5.6 kDa in Figure 7-B. The purified 
antibodies recognized only a single 
polypeptide of approximately 50.9kDa 
on a Western blot parasite membrane 
lysate preparation (Figure 7-C, Lane-
2). The parasite lysate did not reveal 
any band with GST used as negative 
control protein (Figure 7-C, Lane-1) and 
pre immune antiserum (Figure 7-D).
IMMUNOFLUORESCENCE 
MICROSCOPY STUDY
Immunofluorescence confocal 
microscopic images demonstrated 
the three dimensional distribution of 
PfNT3 in parasitized RBCs (Figure 8). 
Localization was in the region of the 
parasite as shown by the proximity of 
the parasite nuclear (Hoechst) stain 
(Figure 8, Panels 2, A-D) and dark 
brown haemozoin pigment in the bright 
field (Figure 8, Panels 1-A, and C, D). 
PfNT3 stained with FITC-conjugated 
secondary antibodies detected the 
protein in ring (Figure 8, panels B-3, 4), 
trophozoite (Figure 8, panels C-3, 4) and 
schizont (Figure 8, panels D-3, 4) stages 
of the parasite. All optical sections 
detected signals on the surfaces of 
intraerythrocytic ring, trophozoite and 
schizont stages of infected parasites in 
antibody treated slides (Figure 8, Panels 
3, 4, B-D). It was neither expressed 
in erythrocyte cytosol nor in RBC 
membrane. A honeycomb staining 
pattern was observed in the mature 
schizonts (Figure 8, panels D-3, 4). There 
were no signals in all preimmune serum 
treated slides taken as control (Figure 8, 
Panels 1-4,A). A large number of cells 
examined showed similar results.
Figure 5: Topology prediction of PfNT3 by using TMHMM, an ExPASy Proteomics tool
Figure 6: Analysis of expressed PfNT3 
recombinant protein on 10% SDS PAGE. Lane 
1-Expressed protein; Lane 2-Purified protein
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IMMUNOELECTRON 
MICROSCOPY
Further localization study was done by 
transmission electron microscopy using 
ultrathin cryosections of the parasites 
(Figure 9). Gold particles localized 
predominantly to the Parasite Plasma 
Membrane. No immunogold labelling 
was observed at the RBCM, TVM or 
any internal organelle including the 
endoplasmic reticulum (Figure 9).
DISCUSSION
Trans membrane transport is a critically 
important physiological process in 
all cells. Membrane transporters are 
responsible for the uptake of essential 
nutrients, modulations of concentrations 
of physiologically relevant chemicals. 
Parasite transporters are of great interest 
as drug targets. ENTs are a unique 
family of proteins with no apparent 
sequence homology to other types of 
transporters, which enable facilitated 
diffusion of nucleosides, nucleoside 
analogs used in chemotherapy across 
cell membranes (Hyde et al. 2001). 
Selective inhibition of parasite protein 
synthesis prevents the formation of the 
NPP suggesting that it originates from 
parasite proteins (Carter et al. 2000). 
With the goal of generating inhibitors 
specific for the target proteins of the 
parasite, several critical and unrelated 
biochemical pathways have been 
Figure 7: Specificity of PfNT3 antibodies. 
Immunoblot analysis with antibodies against 
A-Purified fusion protein (antigen); B-NH2-
terminal sequence after thrombin digestion; 
C-Lane 1-GST (negative control), Lane 
2-Membrane fraction; D-Preimmune serum
                A               B                 C                D 
Figure 8: Smear analysis by deconvoluted immunofluorescence microscopy of PfNT3 in P. 
falciparum infected red blood cells. A-Control slides (Fixed parasites incubated with Pre-
immune antiserum); B-D-With PfNT3 antibodies followed by FITC Conjugated (Green)-
secondary antibodies; B-three parasites in ring stage in a RBC; C-a trophozoite; D-parasites in a 
Schizont; 1-Bright field showing haemozoin pigment (dark spot); 2-Hoescht nuclear stain (Blue) 
indicating parasites; 3-PfNT3 protein (Green); 4-Merge of 2 and 3
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exploited for drug target identification 
(Cunha-Rodrigues et al. 2006).
ANALYSIS OF PfNT3 AND THE 
TRANSLATIONAL PRODUCT
The completely identical sequences 
of the PfNT3 and PfNT3-1-108 PCR 
products with sequences in Plasmo 
DB data base established the identity 
of the gene taken for study of PfNT3 
nucleoside transporter protein.
CHARACTERIZATION OF 
ANTIGEN
A 108bp coding for polypeptide of 36 
amino acids at the N-terminal of the 
protein was selected for cloning and 
expression because of highest local 
average hydrophilicity/antigenicity 
(Cunha-Rodrigues et al. 2006) and a 
hexapeptide is also the approximate 
size of an antigenic determinant (Hopp 
et al. 1981). The deduced amino acid 
sequence predicted homology but not 
complete identity with other nucleoside 
transporter homologues (Figure 3). 
Predicted PfNT3 sequences were 
specific as they were not completely 
matching to ENT sequences of other 
nucleoside transporter homologues 
(Figure 4). These results proved the 
expressed protein to be unique; 
validating it could be a site of novel 
drug target. Interpretation of Figure 5 
is similar to the domain organization of 
ENT family members also.
CHARACTERIZATION OF 
ANTIGEN AND ANTIBODY 
SPECIFICITY
The expressed 31.6 kDa protein as 
estimated from SDS-PAGE analysis 
(Figure 6) was close to the calculated 
molecular mass of the encoded GST 
tagged fusion protein, the protein used 
as antigen. Recognized polypeptide 
with a molecular mass of 31.6 kDa 
in Figure 7-A corresponded with the 
PfNT31-108 GST tagged fusion protein 
size in the data base using ExPASy 
tool (www.expasy.ch, compute pI/
MW). The revealed polypeptide of 5.6 
Figure 9: Transmission Electron Micrograph of ultrathin cryo-sections of the intraerythrocytic 
trophozoite stage of P. falciparum using PfNT3 antibodies. Magnification is x12000 Immunogold 
labelling (10-nm gold particles) of PfNT3 antibodies bound to intraerythrocyte P. falciparum is 
depicted with arrowheads. N-nucleus; NM-nuclear membrane; PPM-parasite plasma membrane; 
PVM-parasitophorous vacuolar membrane; RBCM-red blood cell membrane; FV-food vacuole; 
H-hemozoin; ER-endoplasmic reticulum
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kDa in immunoblotting with thrombin 
digested GST tag removed expressed 
protein in Figure 7-B also matched 
with the calculated molecular weight 
of the encoded protein (compute pI/
MW). The polypeptide on Western blot 
parasite membrane lysate preparation 
(Figure 7-C, Lane-2) was also consistent 
with the molecular mass in the 
database. Specificity of the antibodies 
for PfNT3 epitopes was confirmed 
because the parasite lysate did not 
cross react with GST (Figure-7-C, Lane-
1) and preimmune antiserum (Figure 
7-D). These results proved that the 
antibodies specifically showed up the 
protein used for antibody development. 
These observations proved the 
presence of parasite genome encoded 
endogenously synthesized PfNT3 
protein of parasite membrane origin in 
the P. falciparum parasites.
IMMUNOFLUORESCENCE 
MICROSCOPY STUDY
Presence of PfNT3 in parasitized 
RBCs was detected by reaction of the 
expressed protein with the antibodies 
(Figure 8). The honeycomb staining 
pattern observed in the mature 
schizonts (Figure 8, panels D-3, 4) was 
indicative of PPM staining of developing 
individual merozoites because the PVM 
circumscribes the whole collection of 
merozoites. This staining pattern was 
similar to the observation of PfNT1 
protein (Nicolle et al. 2001) and the 
reticulated staining pattern of PfHT1 
protein shown to be associated with 
PPM (Woodrow et al. 1999).
IMMUNOELECTRON 
MICROSCOPY
Immunoelectron microscopic study 
confirmed the membrane to which 
PfNT3 was localized. This was indicated 
by visualization of immunogold 
particles on the PPM (Figure 9).
CONCLUSION
Results of bioinformatics study on 
homology with ENT homologues, 
phylogeny and topology indicated 
PfNT3 probably to be a nucleoside 
transporter. This may have an important 
role in the survival of the parasite for 
being a route for translocation of the 
nucleosides/nucleobases, the vital 
nutrients essential for synthesis of the 
DNA and RNA of the parasite. Thus, 
it may have an important role in the 
growth and survival of the parasite. 
Immunoblotting, immunofluorescence 
and immunoelectron microscopy 
together established PfNT3 to be an 
integral membrane protein. PfNT3 
appeared to be localized primarily 
to the PPM, although the possibility 
cannot be ruled out that it may be a 
minor constituent of other structures 
and uptake components of the complex 
nucleoside permeation pathway of 
P. falciparum. So, they may not only 
serve as routes for the targeting of 
purine analogs/cytotoxic agents into 
the intracellular parasite, but may also 
serve as antimalarial drug targets in 
their own right. Specific inhibitors can 
be designed against the transporter 
protein for inhibition of growth and 
survival of the malaria parasites. The 
parasite genome encoded protein 
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being expressed in all the blood stages 
in human RBC can be prevented from 
expression by silencing of the gene by 
specific RNA interference or by gene 
editing (Crispr), thereby inhibiting the 
growth and survival of the parasite. 
With probable localization in the 
parasite plasma membrane the vital 
protein poses to be a novel molecular 
drug target for control of the lethal 
malaria caused by P. falciparum.
 Characterization of PfNT3 clone, 
a molecular component of complete 
nucleoside permeation pathway in 
Plasmodium falciparum may thus 
be validated as a new molecular 
chemotherapeutic target. 
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